Summary: Support our channel by purchasing your CBD oil here: NuLeaf Naturals: http://bit.ly/2utFxuf NuLeaf Discount - Use code NEW10 for 10% off your first order! Show Notes On this episode of the CBD School Podcast, I was delighted to be joined by Jahan Marcu, Ph.D. Jahan currently serves as the Chief Scientific Officer and Chief Auditor for Americans For Safe Access and the Patient Focused Certification Program. The mission of Americans for Safe Access (ASA) is to ensure safe and legal access to cannabis (marijuana) for therapeutic use and research. Jahan is one of the top minds working in the cannabis space. His past achievements include: - Receiving a Ph.D for significant contributions to the study of the structure and function of the CB1 receptor and the role of the ECS in bone - Working at the California Pacific Medical Center Research Institute studying the anti-cancer properties of cannabinoids. - Jahan's work has been featured in Forbes, Vice, Nature, Philly Inquirer, CannabisNow, and many others - He is an author for the American Herbal Pharmacopoeia Cannabis Monograph - Jahan is a court-qualified synthetic cannabinoid and cannabis expert In this hour long interview we discussed topics like: - His research on the anti-cancer effects of cannabinoids - Vaping cannabis - what you might want to avoid - The future of legal cannabis access - Advice for cannabis entrepreneurs - Quality control in the cannabis world - And much, much more! If you want to get in touch with Jahan, use the links below: Jahan's Twitter: @jahanmarcu Americans For Safe Access Twitter: @safeaccessnow Jahan also wanted me to share the following links with you. Use them to find out more about Americans For Safe Access and get in touch. safeaccessnow.org/reports info@patientcenteredfocus.org Affiliate Disclosure. My channel and website are supported through affiliate marketing, whereby for referral traffic I receive a small commission from select vendors, at no extra cost to you. This post contains affiliate links. Thanks for your support.
